4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-088815
Chief Financial Officer sold 10,780 shares at an average $8.56 ($92,316)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-29 | Sale : show line 1 in the form 10b5-1 | −1,702 | $8.85 | $15,063 | 328,728 | D |
| 2024-07-29 | Sale : show line 2 in the form 10b5-1 | −9,078 | $8.51 | $77,254 | 319,650 | D |
| Open-market sales · 10,780 sh · avg $8.56 · $92,316 | ||||||
Loading xslF345X05/ownership.xml…